COST-UTILITY ANALYSIS OF ISTENT INJECT IN MILD TO MODERATE PRIMARY OPEN-ANGLE GLAUCOMA IN JAPAN

被引:0
|
作者
Igarashi, A. [1 ]
Falvey, H. [2 ]
Chu, A. [3 ]
Ueyama, M. [4 ]
Zhou, J. [5 ]
Onishi, Y. [4 ]
机构
[1] Univ Tokyo, Tokyo, Japan
[2] Glaukos Corp, San Clemente, CA USA
[3] Glaukos Singapore, Singapore, Singapore
[4] Creat Ceut KK, Tokyo, Japan
[5] Aix Marseille Univ, Marseille, France
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PMD13
引用
收藏
页码:S671 / S671
页数:1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF OMNI® SURGICAL SYSTEM VERSUS ISTENT INJECT® FOR THE TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA IN THE UNITED STATES
    Longo, R.
    Ghinelli, F.
    Morris, L.
    Liu, J.
    Dickerson, J.
    Patel, C.
    Mader, G.
    Nguyen, D.
    Canter, L. B.
    VALUE IN HEALTH, 2022, 25 (12) : S134 - S134
  • [22] Comparison of the iStent Inject® versus the iStent Inject® W-Both in Combination with Cataract Surgery-In Open-Angle Glaucoma
    Deneri, Steffen
    Merte, Ralph-Laurent
    Eter, Nicole
    Bruecher, Viktoria C.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [23] Prospective, Unmasked Evaluation of the iStent®Inject System for Open-Angle Glaucoma: Synergy Trial
    Lilit Voskanyan
    Julián García-Feijoó
    Jose I. Belda
    Antonio Fea
    Anselm Jünemann
    Christophe Baudouin
    Advances in Therapy, 2014, 31 : 189 - 201
  • [24] A Cost-Utility Analysis of Trabecular Bypass Devices Versus Usual Care for Patients With Open-Angle Glaucoma
    Healey, Paul R.
    Tilden, Dominic
    Jackson, Dan
    Aghajanian, Lara
    PHARMACOECONOMICS-OPEN, 2022, 6 (03) : 355 - 365
  • [25] Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma
    Brown, Gary C.
    Brown, Melissa M.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 35 (03) : 145 - 160
  • [26] A Cost-Utility Analysis of Trabecular Bypass Devices Versus Usual Care for Patients With Open-Angle Glaucoma
    Paul R. Healey
    Dominic Tilden
    Dan Jackson
    Lara Aghajanian
    PharmacoEconomics - Open, 2022, 6 : 355 - 365
  • [27] iStent versus iStent inject implantation combined with phacoemulsification in open angle glaucoma
    Shalaby, Wesam Shamseldin
    Lam, Sophia S.
    Arbabi, Amirmohsen
    Myers, Jonathan S.
    Moster, Marlene R.
    Kolomeyer, Natasha N.
    Razeghinejad, Reza
    Shukla, Aakriti Garg
    Hussein, Tarek R.
    Eid, Tarek M.
    Shalaby, Said M.
    Lee, Daniel
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (09) : 2488 - 2495
  • [28] Long-Term Endothelial Safety Profile With iStent Inject in Patients With Open-Angle Glaucoma
    Ahmed, Iqbal Ike K.
    Sheybani, A. R. S. H. A. M.
    DE Francesco, T. I. C. I. A. N. A.
    Lass, Jonathan H.
    Benetz, Beth Ann
    Samuelson, Thomas W.
    Usner, D. A. L. E.
    Katz, L. Jay
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 252 : 17 - 25
  • [29] A CANADIAN COST-UTILITY ANALYSIS OF TWO TRABECULAR MICRO-BYPASS STENTS IMPLANTED AT TIME OF CATARACT SURGERY IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA
    Ahmed, I
    Goeree, R.
    Patel, V
    Murray, J.
    Falvey, H.
    Podbielski, D. W.
    VALUE IN HEALTH, 2018, 21 : S261 - S261
  • [30] Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI From the iStent inject Pivotal Trial
    Samuelson, Thomas W.
    Singh, Inder Paul
    Williamson, Blake K.
    Falvey, Heather
    Lee, Won Chan
    Odom, Dawn
    Mcsorley, David
    Katz, L. Jay
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 229 : 220 - 229